| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |